share_log

Why Entrada Therapeutics Shares Are Trading Lower By 32%; Here Are 31 Stocks Moving Premarket

Why Entrada Therapeutics Shares Are Trading Lower By 32%; Here Are 31 Stocks Moving Premarket

为什么 Entrada Therapeutics 股票的交易价格下跌了 32%;以下是 31 只股票盘前走势
Benzinga Real-time News ·  2022/12/20 06:15
Gainers
获胜者
IceCure Medical Ltd (NASDAQ:ICCM) shares rose 158% to $2.42 in pre-market trading after the company announced interim results from the ICESECRET study for the treatment of patients with small renal masses who cannot be offered kidney-preserving surgery. Exicure, Inc. (NASDAQ:XCUR) shares rose 46% to $1.08 in pre-market trading. Exicure 10% owner CBI USA, Inc. acquired a total of 3,400,000 shares at an average price of $1.60. Verona Pharma plc (NASDAQ:VRNA) rose 39.3% to $18.80 in pre-market trading after the company reported positive results of its Phase 3 ENHANCE-1 trial evaluating nebulized ensifentrine for the maintenance treatment of chronic obstructive pulmonary disease. Otonomy...
iCecure 医疗有限公司 纳斯达克股票代码:ICCM)的股价在盘前交易中上涨了158%,至2.42美元,此前该公司公布了ICESECRET研究的中期结果,该研究旨在治疗无法接受肾脏保存手术的小肾...
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发